About Us
Our multi-disciplinary team delivers innovative, high precision, regulatory-compliant decision support tools that empowers physicians, accelerates diagnosis, and elevates patient outcomes
Who We Are
Vita Imaging is a pioneering medical technology (MedTech) company dedicated to revolutionizing early cancer screening and detection. By combining advanced hardware with advanced technology, we develop high-velocity physician support systems that help clinicians identify pre-cancerous and malignant lesions faster, safer, and with unprecedented accuracy.
Our Technology
Our flagship device, AURA™, is a patent-protected, non-invasive imaging and spectroscopy platform developed by leading scientists, clinicians and engineers at the renowned British Columbia Cancer Agency (BCCA). Harnessing the power of Raman spectroscopy and machine learning algorithms, AURA™ distinguishes between benign and malignant skin lesions real time in under 1.5 seconds—eliminating patient anxiety and reducing the need for invasive biopsies. Armed with an officially recognized Category III CPT Code, our technology is positioned at the forefront of AI-supported clinical diagnostics.
Vision
We aim to be the global MedTech leader in the Point-of-Care (POC) cancer detection market. By delivering seamless, intelligent, and scalable digital health solutions, we empower healthcare providers to save lives through immediate, data-driven diagnostic support.
Mission
Our mission is to become the preeminent leader in the development of innovative diagnostic technology supporting Physicians and healthcare practitioners in the accurate and rapid screening, detection and identification of early and advanced cancer in the skin and internal organs.
Values
To be a customer-centric company that produces high quality, point of care, cancer diagnostic systems that are trusted by the healthcare community and patients.
Leadership
Thinh Tran
Chairman / CEO
Prior to Vita Imaging , Thinh is the Founder, CEO, & Chairman of V-Silicon, a leader in the Smart TV market delivering best in class picture and audio quality. He was previously the Founder, Chairman, & CEO of Sigma Designs since its inception in 1982 – which he built from a humble start-up into a multi-billion dollar publicly traded NASDAQ company – making him one of the longest serving CEOs on the NASDAQ. He also has extensive experience raising capital, executing M&A transactions, and providing guidance to many start-ups. Prior to Sigma Designs, He was employed by Amdahl Corporation and Trilogy Systems Corporation, leaders in the IBM mainframe computer market. He holds a B.S.E.E. from the University of Wisconsin & M.S.E.E. from Stanford University.
Victoria Reade
Chief Operations Officer
Victoria Reade is a trailblazing healthcare executive, Big 4 IT Consultant, and MedTech/Digital Health entrepreneur with 25+ years leadership experience. Since Vita Imaging was founded in 2019, Victoria has served as COO spearheading clinical research studies, global regulatory compliance, international market expansion, reimbursement, product development, and partners with the CEO on fundraising initiatives. Previously, Victoria was an Executive at leading integrated delivery systems, Fortune 500 HMO, co-Founder & CEO of a MedTech vision restoration company.
Victoria has an MBA from Pace University, a BSN from University of Tennessee Health Science Center and is a Fellow of the Royal Society of the Arts. She advises start-ups at accelerators.
Dzung Wright
Interim CFO
Dzung is the interim Chief Financial Officer of Vita Imaging, Inc. She has over 30 years of experience in the financial industry, holding senior financial positions at multiple publicly traded and startup companies over a wide range of industries such as medical, telecommunications, device technology, digital arts, mobile devices, and internet technology.
Before joining Vita Imaging, Dzung held senior finance roles at Vivus Inc., Controlnet Inc., Foneweb Inc., and Microlambda Wireless Inc. She has a proven track record of success in leading and managing financial teams, and she has a deep understanding of financial reporting, analysis, and planning.
Dzung is a graduate of San Jose State University and holds a Bachelor’s degree in Business Administration and Accounting.
Scientific, Inventor & Clinical Partners
Haishan Zeng, PhD
Distinguished Scientist & Lead Inventor
Dr. Zeng is a Distinguished Scientist with the Integrative Oncology Department (Imaging Unit) of the BCCA & Professor of Dermatology, Pathology, and Physics at UBC. He has 170+ Peer Reviewed Publications and 28+ patents related to optical diagnosis and therapy. Dr. Zeng holds a PhD in Biophysics from UBC and is the lead Inventor of the Rapid Raman Spectroscopy Platform Technology developed at BCCA, including the AURA™ and CORE.
Harvey Lui, MD, FRCPC
Lead Principal Investigator & Co-Inventor
Dr. Lui is a Professor and former Head of the Department of Dermatology and Skin Science at UBC. He was formerly the President of the International League of Dermatological Societies, an active member of the Photomedicine Society, and Canadian Dermatology Association, amongst other medical organizations. Dr. Lui received his MD from UBC and completed an advanced fellowship at Massachusetts General Hospital and Harvard Medical School.
Sunil Kalia, MD, FRCP
Principal Investigator
Dr. Kalia is co-Director of the Psoriasis & Phototherapy Clinic at Vancouver General Hospital and Assistant Professor in Dermatology at UBC. He is President of the Dermatology Society of British Columbia & Board Director, Dermatology. Dr. Kalia is a graduate of the University of Calgary and has a Masters in Healthcare & Epidemiology and completed photo dermatology training in the USA, Australia and Europe.
Michael Short, PhD
Scientific Collaborator & Co-Inventor
Dr. Short has been a Research Associate at BCCA for over 12 years. He is the Lead and/or co-author of 31 scientific papers in peer reviewed journals featuring medical applications for Raman spectroscopy. He is a named co-inventor on 6 Raman Spectroscopy patents. He holds a PhD in Physics from Simon Fraser University in Canada.
Jianhua Zhao, PhD
Scientific Collaborator & Co-Inventor
Dr. Zhao is a Research Associate at BCCA and UBC. He has published 90+ scientific papers and has 5+ patent applications based on his specialized work in Raman Spectroscopy, diffuse reflectance, and fluorescence for skin cancer diagnosis. He holds a PhD in Optical Engineering from Shandong University in collaboration with University of California Santa Barbara.
Katharine Ball, MD
Physician Advisor
Dr. Katharine Ball is a Board-Certified Dermatologist with advanced training in cutaneous laser surgery, complex skin reconstruction, and Mohs surgery from a Fellowship at UC Irvine. Dr. Ball is in active practice at the California Skin Institute. She is an experienced researcher with peer reviewed publications.
Dr. Ball graduated from Sidney Kimmel Medical College and completed her post-doctorate training at Stanford University Dermatology Center.